Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A trial looking at pravastatin with chemotherapy for non small cell lung cancer (LungstarPK)
Cancer type:
Lung cancer
Non small cell lung cancer
Status:
Results
Phase:
Phase 2
This trial was trying to find out more about having a statin drug at the same time as cisplatin and docetaxel for non small cell lung cancer.
More about this trial
Doctors use chemotherapy to treat advanced non small cell lung cancer. The chemotherapy drugs in this trial were two of the most commonly used.
Statins are medicines that people usually take to lower their cholesterol. We know from earlier research that they may also affect cancer cells. In this trial the researchers wanted to find out more about how a statin called pravastatin mixes with cisplatin and docetaxel.
The aims of the trial were to
- Learn more about how the statin drug interacts with the chemotherapy drugs in your body
- Find out about the side effects of having both treatments together
Summary of results
There are no results available for this trial. The researchers were unable to recruit enough patients.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Dr Peter Schmid
Professor Michael J Seckl
Supported by
Experimental Cancer Medicine Centre (ECMC)
Sanofi
Freephone 0808 800 4040
Last review date
CRUK internal database number:
1707
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Around 1 in 5 people take part in clinical trials
